tiprankstipranks
Trending News
More News >
Genmab’s Promising Rina-S Developments Drive Buy Rating Amid Strong Initial Study Results
PremiumRatingsGenmab’s Promising Rina-S Developments Drive Buy Rating Amid Strong Initial Study Results
11d ago
Genmab’s Rina-S: Promising Efficacy and Strategic Growth Potential in Endometrial Cancer Treatment
Premium
Ratings
Genmab’s Rina-S: Promising Efficacy and Strategic Growth Potential in Endometrial Cancer Treatment
15d ago
Genmab A/S Updates Articles to Enhance Capital Flexibility
Premium
Company Announcements
Genmab A/S Updates Articles to Enhance Capital Flexibility
17d ago
Genmab price target lowered to $35 from $37 at H.C. Wainwright
PremiumThe FlyGenmab price target lowered to $35 from $37 at H.C. Wainwright
24d ago
Genmab Executes Share Buy-back Transactions in May 2025
Premium
Company Announcements
Genmab Executes Share Buy-back Transactions in May 2025
26d ago
Genmab’s Strong Financial Performance and Promising Pipeline Justify Buy Rating
Premium
Ratings
Genmab’s Strong Financial Performance and Promising Pipeline Justify Buy Rating
26d ago
Genmab reports Q1 revenue $715M vs. $603M last year
PremiumThe FlyGenmab reports Q1 revenue $715M vs. $603M last year
30d ago
Genmab reaffirms FY25 guidance
Premium
The Fly
Genmab reaffirms FY25 guidance
30d ago
Genmab Executes Share Buy-back Transactions in Early May 2025
Premium
Company Announcements
Genmab Executes Share Buy-back Transactions in Early May 2025
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100